2027 Summer Internship Opportunities – Join Our Talent Community
Acadia Pharmaceuticals Inc.
Summary
At Acadia Pharmaceuticals, our Summer Internship Program provides students with meaningful, hands-on experience in a collaborative and innovative environment. Interns have the opportunity to contribute to impactful projects, gain exposure to the pharmaceutical industry, develop professional skills, and collaborate with experienced professionals across various business functions.
Job description
About Our Summer Internship Program
At Acadia Pharmaceuticals, our Summer Internship Program provides students with meaningful, hands-on experience in a collaborative and innovative environment. Interns have the opportunity to contribute to impactful projects, gain exposure to the pharmaceutical industry, develop professional skills, and collaborate with experienced professionals across various business functions.
Internship Eligibility
Eligibility requirements may vary depending on the specific internship opportunity and its educational and technical requirements.
Undergraduate Students
- Must be currently enrolled in an accredited undergraduate degree program.
- Typically entering their junior or senior year following the Summer 2027 Internship Program.
- Expected graduation date between December 2027 and June 2029.
Graduate Students (Master's or PhD)
Certain internship opportunities may be available to students pursuing a Master's or PhD degree. Advanced degree requirements will apply only to positions requiring specialized academic, technical, or research knowledge. Additional eligibility requirements will be outlined in individual internship postings.
Stay Connected!
Please note: This is not an application for a specific internship position. By submitting your information through this form, you will join Acadia's Summer 2027 Internship Talent Community and receive updates when internship applications become available.
Requirements
- Must be currently enrolled in an accredited undergraduate degree program
- Typically entering junior or senior year following the Summer 2027 Internship Program
- Expected graduation date between December 2027 and June 2029
- Certain opportunities may require pursuing a Master's or PhD degree
Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Business Travel Coverage
- Employee Assistance Program
- 401(k) Matching
- Employee Stock Purchase Plan
- Paid Vacation
- Paid Holidays
- Paid Sick Time
- Paid Parental Leave
- Tuition Assistance
Company overview
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in San Diego, California, founded in 1993. The company specializes in developing and commercializing innovative therapies for underserved neurological disorders and rare diseases. Acadia has pioneered the first and only FDA-approved treatments for Parkinson's disease psychosis (NUPLAZID®) and Rett syndrome (DAYBUE®). With a workforce of 501-1,000 employees, the company maintains a robust pipeline focused on addressing unmet medical needs in Alzheimer's disease psychosis, Lewy body dementia psychosis, Prader-Willi syndrome, and other central nervous system disorders. Acadia operates with a mission to transform scientific promise into meaningful innovations that improve patient lives, particularly in neurological and rare disease communities where treatment options are limited. The company is publicly traded on NASDAQ under the symbol ACAD and has established itself as a leader in neuroscience therapeutics through its commitment to research, development, and patient-centered care.